The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 333:662-664 September 7, 1995 Number 10
NextNext

Ataxia–Telangiectasia — Broad Implications for a Rare Disorder

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Ataxia–telangiectasia is a rare autosomal recessive disorder with diverse clinical manifestations. Patients typically come to medical attention in early childhood because of ataxia, and this is followed by progressive neuromotor degeneration, usually resulting in dependence on a wheelchair by 10 years of age. In addition to cerebellar degeneration, patients with ataxia–telangiectasia have elevated levels of alpha-fetoprotein, various immunologic deficiencies, growth retardation, premature aging, chromosomal instability, an increased frequency of lymphoreticular cancers, and hypersensitivity to ionizing radiation and radiomimetic drugs.1 The defective gene responsible for this pleiotropic disorder (ATM) was recently identified by a multinational group led by investigators . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.